Cybin Inc
Change company Symbol lookup
Select an option...
CLXPF Cybin Inc
RVVTF Revive Therapeutics Ltd
SHRMF Braxia Scientific Corp
LKYSF Numinus Wellness Inc
MNMD Mind Medicine (MindMed) Inc
CMPS Compass Pathways PLC
TLIS Talis Biomedical Corp
DVN Devon Energy Corp
BCX BlackRock Resources & Commodities Strategy Trust
BRKS Brooks Automation Inc

Based in Canada
Company profile

Cybin Inc., formerly Clarmin Explorations Inc., is a Canada-based life sciences company. The Company is focused on developing psychedelic pharmaceutical and non-psychedelic nutraceutical-based products. Its subsidiaries include Natures Journey Inc. and Serenity Life Sciences Inc. Serenity Life Sciences Inc. is focused on research and development of psilocybin-based medications. Natures Journey Inc. operates the Journey brand, which specializes in developing medicinal mushroom products. It has a drug delivery platform developed to administer psychedelic therapies and bypass liver metabolism. The Company also focus is on the development of treatment regimens consisting of psychedelic molecules and related clinical protocols.

Day's Change
-0.01 (-0.61%)
B/A Size
Day's High
Day's Low

Today's volume of 211,237 shares is on pace to be much lighter than CLXPF's 10-day average volume of 781,796 shares.


Michigan Medicine Awards Contract to 3M for Complete Suite of AI-powered Clinician and Revenue Cycle Technology

9:45 am ET March 10, 2021 (PR Newswire) Print

To address the growing administrative burden on clinicians and the inefficiencies and added costs of unconnected systems, Michigan Medicine will partner with 3M Health Information Systems to implement a full portfolio of 3M technology across its health care system. Powered by artificial intelligence (AI), 3M's clinician and revenue cycle solutions will help Michigan Medicine reduce physician stress and bolster thorough clinical documentation, strengthening communication between clinicians and revenue cycle teams to promote accurate and actionable data for improved patient care.

3M's suite of AI-enabled solutions, fully integrated with Michigan Medicine's electronic health record (EHR), will be implemented across the health system's three hospitals and 125 outpatient clinics, including the University of Michigan Health System and Medical School, one of the state's largest health care complexes.

The contract includes 3M(TM) M*Modal Fluency Direct front-end speech understanding, computer-assisted physician documentation (CAPD), and virtual assistant solutions; automated clinical intelligence provided by 3M(TM) M*Modal CDI Engage One(TM) and 3M(TM) M*Modal HCC Management; and the 3M(TM) 360 Encompass(TM) System, used by more than 2,000 U.S. health care organizations for computer-assisted coding, CDI workflows, concurrent quality metrics and analytics.

"Michigan Medicine has a long history of cutting-edge research and premier patient care," said Jeff Terrell, MD, Associate Chief Medical Information Officer, Professor, Otolaryngology-Head and Neck Surgery for the health system. "To advance this mission, we plan to use 3M technology to ease the documentation burden and streamline EHR work for Michigan Medicine providers and staff across the continuum of care settings, to create more time for their value-added patient care activities.

"Michigan Medicine believes that technology is one way to become more efficient, reduce cost and reduce administrative burden for our clinicians," added Benjie Johnson, Chief Officer Revenue Cycle Management. "We are working with 3M as a strategic technology vendor to transform how we create and improve clinical documentation. It is our goal in the next few years to effectively use ambient technology that will free up clinicians and enable them to focus on patient care."

More information about 3M Health Information Systems clinician and revenue cycle solutions is available at or by calling 800-367-2447.

About Michigan Medicine

At Michigan Medicine, we advance health to serve Michigan and the world. We pursue excellence every day in our three hospitals, 125 clinics and home care operations that handle more than 2.3 million outpatient visits a year, as well as educate the next generation of physicians, health professionals and scientists in our U-M Medical School.

Michigan Medicine includes the top ranked U-M Medical School and the University of Michigan Health System, which includes the C.S. Mott Children's Hospital, Von Voigtlander Women's Hospital, University Hospital, the Frankel Cardiovascular Center and the Rogel Cancer Center. Michigan Medicine's adult hospitals were ranked no. 11 in the nation by U.S. News and World Report in 2020-21 and C.S. Mott Children's Hospital was the only children's hospital in Michigan nationally ranked in all 10 pediatric specialties analyzed by U.S. News and World Report for 2020-21. The U-M Medical School is one of the nation's biomedical research powerhouses, with total research funding of more than $500 million.

More information is available at

About 3MAt 3M (NYSE: MMM), we apply science in collaborative ways to improve lives daily. With $32 billion in sales, our 96,000 employees connect with customers all around the world. Learn more about 3M's creative solutions to the world's problems at or on Twitter @3M or @3MNews.

CDI Engage One and 360 Encompass System are registered trademarks of 3M Company.

View original content to download multimedia:


comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.